FDA ponders approaches to curbing adverse effects of drug used against cystic acne.
Marwick
C
C
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000152:Acne Vulgaris / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015474:Isotretinoin; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014212:Tretinoin / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D014212:Tretinoin; D015474:Isotretinoin